Overview

A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes Mellitus

Status:
Terminated
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
Many drugs used for the treatment of Type 2 Diabetes Mellitus cause the body to retain water. This study will assess whether or not GW677954 causes the body to retain fluid.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Insulin
Insulin, Globin Zinc